Christopher J. Kaler

ORCID: 0000-0003-2310-7735
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Ocular Oncology and Treatments
  • Immunotherapy and Immune Responses
  • Ubiquitin and proteasome pathways
  • Immune cells in cancer
  • Protein Kinase Regulation and GTPase Signaling
  • Bladder and Urothelial Cancer Treatments
  • Cellular transport and secretion
  • Traumatic Brain Injury and Neurovascular Disturbances
  • Nanoplatforms for cancer theranostics
  • Traumatic Ocular and Foreign Body Injuries
  • Facial Trauma and Fracture Management

Sylvester Comprehensive Cancer Center
2022

University of Miami
2020-2022

National Cancer Institute
2017

Center for Cancer Research
2017

Uveal melanoma (UM) is the most common primary cancer of eye and associated with a high rate metastatic death. UM can be stratified into two main classes based on risk, class 1 having low risk 2 risk. Class have distinctive genomic, transcriptomic, histopathologic, clinical phenotype characterized by biallelic inactivation BAP1 tumor-suppressor gene, an immune-suppressive microenvironment enriched for M2-polarized macrophages, poor response to checkpoint-inhibitor immunotherapy. To identify...

10.3390/cancers14153678 article EN Cancers 2022-07-28

Uveal melanoma (UM) is the most common primary cancer of eye and associated with a high rate metastatic death. UM can be stratified into two main classes based on risk, class 1 having low risk 2 risk. Class have distinctive genomic, transcriptomic, histopathologic, clinical phenotype characterized by biallelic inactivation BAP1 tumor suppressor gene, an immune suppressive microenvironment enriched for M2-polarized macrophages, poor response to checkpoint inhibitor immunotherapy. To identify...

10.20944/preprints202206.0236.v1 preprint EN 2022-06-16

Abstract Uveal melanoma (UM) is the most common primary eye cancer and has a high rate of metastasis with liver tropism. UM can be stratified according to metastatic risk into low Class 1 2 tumor. Biallelic mutational inactivation tumor suppressor BAP1 quintessential molecular feature UM, but mechanism by which loss leads poorly understood. We recently showed using single-cell RNA sequencing that microenvironment characterized large numbers inhibitory T cells macrophages. Taken together,...

10.1158/1538-7445.am2021-2764 article EN cc-by-nc Cancer Research 2021-07-01
Coming Soon ...